Intracellular iron transport and storage: From molecular mechanisms to health implications

Antioxidants and Redox Signaling

Volumn 10, Issue 6, 2008, Pages 997-1030

  Mackenzie, Elizabeth L ^a   Iwasaki, Kenta ^a   Tsuji, Yoshiaki ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 PYRIDYLCARBOXALDEHYDE ISONICOTINOYL HYDRAZONE DERIVATIVE; BML 210; CD71 ANTIGEN; CERULOPLASMIN; CHELATING AGENT; DEFERIPRONE; DEFEROXAMINE; EBSELEN; FERRITIN; FERROPORTIN; FRATAXIN; FREE RADICAL; HEPCIDIN; HEPHAESTIN; HEREDITARY HEMOCHROMATOSIS PROTEIN; IDEBENONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; IRON REGULATORY FACTOR; IRON SULFUR PROTEIN; MITO VITAMIN E; MITOQUINONE; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; PYRIDOXAL ISONICOTINOYLHYDRAZONE; REACTIVE OXYGEN METABOLITE; REGULATOR PROTEIN; TRANSFERRIN; TRANSFERRIN RECEPTOR; TRANSFERRIN RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ALZHEIMER DISEASE; BIOGENESIS; CELL DAMAGE; CELL METABOLISM; CELL RESPIRATION; DNA SYNTHESIS; DRUG MECHANISM; ENERGY YIELD; ERYTHROLEUKEMIA CELL; FERRITIN BLOOD LEVEL; FRIEDREICH ATAXIA; GENE MUTATION; GENETIC DISORDER; GENETIC REGULATION; HEME SYNTHESIS; HEMOCHROMATOSIS; HOMEOSTASIS; HUMAN; INFLAMMATION; INTESTINE ABSORPTION; INTESTINE CELL; IRON ABSORPTION; IRON OVERLOAD; IRON RESPONSIVE ELEMENT; IRON STORAGE; IRON TRANSPORT; MITOCHONDRION; NERVE DEGENERATION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; TISSUE DISTRIBUTION; TRANSCRIPTION REGULATION;

ANIMALS; BIOLOGICAL TRANSPORT; HUMANS; IRON; IRON OVERLOAD; IRON-BINDING PROTEINS; MICE; OXIDATIVE STRESS; TRANSFERRIN;

EID: 41349120026     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2007.1893     Document Type: Review

References (342)

1. Abboud S and Haile DJ. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem 275: 19906-19912, 2000.
2. Adamec J, Rusnak F, Owen WG, Naylor S, Benson LM, Gacy AM, and Isaya G. Iron-dependent self-assembly of recombinant yeast frataxin: implications for Friedreich ataxia. Am J Hum Genet 67: 549-562, 2000.
3. Adams PC, Powell LW, and Halliday JW. Isolation of a human hepatic ferritin receptor. Hepatology 8: 719-721, 1988.
4. Aisen P, Leibman A, and Zweier J. Stoichiometric and site characteristics of the binding of iron to human transferrin. J Biol Chem 253: 1930-1937, 1978.
5. Al-Mahdawi S, Pinto RM, Varshney D, Lawrence L, Lowrie MB, Hughes S, Webster Z, Blake J, Cooper JM, King R, and Pook MA. GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology. Genomics 88: 580-590, 2006.
6. Alam J, Camhi S, and Choi AM. Identification of a second region upstream of the mouse heme oxygenase-1 gene that functions as a basal level and inducer-dependent transcription enhancer. J Biol Chem 270: 11977-11984, 1995.
7. Anderson GJ, Faulk WP, Arosio P, Moss D, Powell LW, and Halliday JW. Identification of H- and L-ferritin subunit binding sites on human T and B lymphoid cells. Br J Haematol 73: 260-264, 1989.
8. Andriopoulos B, Hegedusch S, Mangin J, Riedel HD, Hebling U, Wang J, Pantopoulos K, and Mueller S. Sustained hydrogen peroxide induces iron uptake by transferrin receptor-1 independent of the iron regulatory protein/iron- responsive element network. J Biol Chem 282: 20301-20308, 2007.
9. Arosio P and Levi S. Ferritin, iron homeostasis, and oxidative damage. Free Radic Biol Med 33: 457-463, 2002.
10. Arosio P, Yokota M, and Drysdale JW. Structural and immunological relationships of isoferritins in normal and malignant cells. Cancer Res 36: 1735-1739, 1976.
11. Arranz Caso JA, Garcia Tena J, Llorens MM, and Moreno R. High serum ferritin concentration in an AIDS patient with miliary tuberculosis. Clin Infect Dis 25: 1263-1264, 1997.
12. Askwith C, Eide D, Van Ho A, Bernard PS, Li L, Davis-Kaplan S, Sipe DM, and Kaplan J. The FET3 gene of S cerevisiae encodes a multicopper oxidase required for ferrous iron uptake. Cell 76: 403-410, 1994.
13. Babcock M, de Silva D, Oaks R, Davis-Kaplan S, Jiralerspong S, Montermini L, Pandolfo M, and Kaplan J. Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. Science 276: 1709-1712, 1997.
14. Babitt JL, Huang FW, Wrighting DM, Xia Y, Sidis Y, Samad TA, Campagna JA, Chung RT, Schneyer AL, Woolf CJ, Andrews NC, and Lin HY. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet 38: 531-539, 2006.
15. Babitt JL, Huang FW, Xia Y, Sidis Y, Andrews NC, and Lin HY. Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. J Clin Invest 117: 1933-1939, 2007.
16. Barton JC and Bertoli LF. Hemochromatosis: the genetic disorder of the twenty-first century. Nat Med 2: 394-395, 1996.
17. Battistini A, Coccia EM, Marziali G, Bulgarini D, Scalzo S, Fiorucci G, Romeo G, Affabris E, Testa U, Rossi GB, and Peschle C. Intracellular heme coordinately modulates globin chain synthesis, transferrin receptor number, and ferritin content in differentiating Friend erythroleukemia cells. Blood 78: 2098-2103, 1991.
18. Beard J. Iron deficiency alters brain development and functioning. J Nutr 133: 1468S-1472S, 2003.
19. Beaumont C, Leneuve P, Devaux I, Scoazec JY, Berthier M, Loiseau MN, Grandchamp B, and Bonneau D. Mutation in the iron responsive element of the L ferritin mRNA in a family with dominant hyperferritinaemia and cataract. Nat Genet 11: 444-446, 1995.
20. Beaumont C, Seyhan A, Yachou AK, Grandchamp B, and Jones R. Mouse ferritin H subunit gene: functional analysis of the promoter and identification of an upstream regulatory element active in erythroid cells. J Biol Chem 269: 20281-20288, 1994.
21. Bernstein SE. J Lab Clin Med 110: 690-705, 1987.
22. Bianchi L, Tacchini L, and Cairo G. HIF-1-mediated activation of transferrin receptor gene transcription by iron chelation. Nucleic Acids Res 27: 4223-4227, 1999.
23. Bidichandani SI, Ashizawa T, and Patel PI. The GAA triplet-repeat expansion in Friedreich ataxia interferes with transcription and may be associated with an unusual DNA structure. Am J Hum Genet 62: 111-121, 1998.
24. Bishop GM, Robinson SR, Liu Q, Perry G, Atwood CS, and Smith MA. Iron: a pathological mediator of Alzheimer disease? Dev Neurosci 24: 184-187, 2002.
25. Bjorkman PJ and Parham P. Structure, function, and diversity of class I major histocompatibility complex molecules. Annu Rev Biochem 59: 253-288, 1990.
26. Boddaert N, Le Quan Sang KH, Rotig A, Leroy-Willig A, Gallet S, Brunelle F, Sidi D, Thalabard JC, Munnich A, and Cabantchik ZI. Selective iron chelation in Friedreich ataxia: biologic and clinical implications. Blood 110: 401-408, 2007.
27. Boutet SC, Disatnik MH, Chan LS, Iori K, and Rando TA. Regulation of pax3 by proteasomal degradation of monoubiquitinated protein in skeletal muscle progenitors. Cell 130: 349-362, 2007.
28. Bradley JL, Blake JC, Chamberlain S, Thomas PK, Cooper JM, and Schapira AH. Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia. Hum Mol Genet 9: 275-282, 2000
29. Branda SS, Cavadini P, Adamec J, Kalousek F, Taroni F, and Isaya G. Yeast and human frataxin are processed to mature form in two sequential steps by the mitochondrial processing peptidase. J Biol Chem 274: 22763-22769, 1999.
30. Bulteau AL, O'Neill HA, Kennedy MC, Ikeda-Saito M, Isaya G, and Szweda LI. Frataxin acts as an iron chaperone protein to modulate mitochondrial aconitase activity. Science 305: 242-245, 2004.
31. Burnett R, Melander C, Puckett JW, Son LS, Wells RD, Dervan PB, and Gottesfeld JM. DNA sequence-specific polyamides alleviate transcription inhibition associated with long GAA.TTC repeats in Friedreich's ataxia. Proc Natl Acad Sci U S A 103: 11497-11502, 2006.
32. Cai CX, Birk DE, and Linsenmayer TF. Ferritin is a developmentally regulated nuclear protein of avian corneal epithelial cells. J Biol Chem 272: 12831-12839, 1997.
33. Cai CX, Birk DE, and Linsenmayer TF. Nuclear ferritin protects DNA from UV damage in corneal epithelial cells. Mol Biol Cell 9: 1037-1051, 1998.
34. Caltagirone A, Weiss G, and Pantopoulos K. Modulation of cellular iron metabolism by hydrogen peroxide: effects of H2O2 on the expression and function of iron-responsive element-containing mRNAs in B6 fibroblasts. J Biol Chem 276: 19738-19745, 2001.
35. Camaschella C, Roetto A, Cali A, De Gobbi M, Garozzo G, Carella M, Majorano N, Totaro A, and Gasparini P. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet 25: 14-15, 2000.
36. Camaschella C, Roetto A, and De Gobbi M. Genetic haemochromatosis: genes and mutations associated with iron loading. Best Pract Res Clin Haematol 15: 261-276, 2002.
37. Campanella A, Isaya G, O'Neill HA, Santambrogio P, Cozzi A, Arosio P, and Levi S. The expression of human mitochondrial ferritin rescues respiratory function in frataxin-deficient yeast. Hum Mol Genet 13: 2279-2288, 2004.
38. Campuzano V, Montermini L, Molto MD, Pianese L, Cossee M, Cavalcanti F, Monros E, Rodius F, Duclos F, Monticelli A, Zara F, Canizares J, Koutnikova H, Bidichandani SI, Gellera C, Brice A, Trouillas P, De Michele G, Filla A, De Frutos R, Palau F, Patel PI, Di Donato S, Mandel JL, Cocozza S, Koenig M, and Pandolfo M. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271: 1423-1427, 1996.
39. Canonne-Hergaux F, Gruenheid S, Ponka P, and Gros P. Cellular and subcellular localization of the Nramp2 iron transporter in the intestinal brush border and regulation by dietary iron. Blood 93: 4406-4417, 1999.
40. Canonne-Hergaux F, Zhang AS, Ponka P, and Gros P. Characterization of the iron transporter DMT1 (NRAMP2/DCT1) in red blood cells of normal and anemic mk/mk mice. Blood 98: 3823-3830, 2001.
41. Carella M, D'Ambrosio L, Totaro A, Grifa A, Valentino MA, Piperno A, Girelli D, Roetto A, Franco B, Gasparini P, and Camaschella C. Mutation analysis of the HLA-H gene in Italian hemochromatosis patients. Am J Hum Genet 60: 828-832, 1997.
42. Casey JL, Hentze MW, Koeller DM, Caughman SW, Rouault TA, Klausner RD, and Harford JB. Iron-responsive elements: regulatory RNA sequences that control mRNA levels and translation. Science 240: 924-928, 1988.
43. Cass WA, Grondin R, Andersen AH, Zhang Z, Hardy PA, Hussey-Andersen LK, Rayens WS, Gerhardt GA, and Gash DM. Iron accumulation in the striatum predicts aging-related decline in motor function in rhesus monkeys. Neurobiol Aging 28: 258-271, 2007.
44. Cavadini P, Adamec J, Taroni F, Gakh O, and Isaya G. Two-step processing of human frataxin by mitochondrial processing peptidase: precursor and intermediate forms are cleaved at different rates. J Biol Chem 275: 41469-41475, 2000.
45. Cavadini P, O'Neill HA, Benada O, and Isaya G. Assembly and iron-binding properties of human frataxin, the protein deficient in Friedreich ataxia. Hum Mol Genet 11: 217-227, 2002.
46. Chan K, Lu R, Chang JC, and Kan YW. NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development. Proc Natl Acad Sci U S A 93: 13943-13948, 1996.
47. Chantrel-Groussard K, Geromel V, Puccio H, Koenig M, Munnich A, Rotig A, and Rustin P. Disabled early recruitment of antioxidant defenses in Friedreich's ataxia. Hum Mol Genet 10: 2061-2067, 2001.
48. Chen OS, Hemenway S, and Kaplan J. Inhibition of Fe-S cluster biosynthesis decreases mitochondrial iron export: evidence that Yfh1p affects Fe-S cluster synthesis. Proc Natl Acad Sci U S A 99: 12321-12326, 2002.
49. Chen TT, Li L, Chung DH, Allen CD, Torti SV, Torti FM, Cyster JG, Chen CY, Brodsky FM, Niemi EC, Nakamura MC, Seaman WE, and Daws MR. TIM-2 is expressed on B cells and in liver and kidney and is a receptor for H-ferritin endocytosis. J Exp Med 202: 955-965, 2005.
50. Cheng Y, Zak O, Aisen P, Harrison SC, and Walz T. Structure of the human transferrin receptor-transferrin complex. Cell 116: 565-576, 2004.
51. Chinnery PF, Crompton DE, Birchall D, Jackson MJ, Coulthard A, Lombes A, Quinn N, Wills A, Fletcher N, Mottershead JP, Cooper P, Kellett M, Bates D, and Burn J. Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation. Brain 130: 110-119, 2007.
52. Collawn JF, Stangel M, Kuhn LA, Esekogwu V, Jing SQ, Trowbridge IS, and Tainer JA. Transferrin receptor internalization sequence YXRF implicates a tight turn as the structural recognition motif for endocytosis. Cell 63: 1061-1072, 1990.
53. Condo I, Ventura N, Malisan F, Rufini A, Tomassini B, and Testi R. In vivo maturation of human frataxin. Hum Mol Genet 16: 1534-1540, 2007.
54. Connor JR, Boeshore KL, Benkovic SA, and Menzies SL. Isoforms of ferritin have a specific cellular distribution in the brain. J Neurosci Res 37: 461-465, 1994.
55. Conrad ME, Umbreit JN, Moore EG, and Parmley RT. Hereditary hemochromatosis: a prevalent disorder of iron metabolism with an elusive etiology. Am J Hematol 47: 218-224, 1994.
56. Cooperman SS, Meyron-Holtz EG, Olivierre-Wilson H, Ghosh MC, McConnell JP, and Rouault TA. Microcytic anemia, erythropoietic protoporphyria, and neurodegeneration in mice with targeted deletion of iron-regulatory protein 2. Blood 106: 1084-1091, 2005.
57. Corsi B, Cozzi A, Arosio P, Drysdale J, Santambrogio P, Campanella A, Biasiotto G, Albertini A, and Levi S. Human mitochondrial ferritin expressed in HeLa cells incorporates iron and affects cellular iron metabolism. J Biol Chem 277: 22430-22437, 2002.
58. Cossee M, Puccio H, Gansmuller A, Koutnikova H, Dierich A, LeMeur M, Fischbeck K, Dolle P, and Koenig M. Inactivation of the Friedreich ataxia mouse gene leads to early embryonic lethality without iron accumulation. Hum Mol Genet 9: 1219-1226, 2000.
59. Courselaud B, Pigeon C, Inoue Y, Inoue J, Gonzalez FJ, Leroyer P, Gilot D, Boudjema K, Guguen-Guillouzo C, Brissot P, Loreal O, and Ilyin G. C/EBPalpha regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism: cross-talk between C/EBP pathway and iron metabolism. J Biol Chem 277: 41163-41170, 2002.
60. Cozzi A, Corsi B, Levi S, Santambrogio P, Albertini A, and Arosio P. Overexpression of wild type and mutated human ferritin Hchain in HeLa cells: in vivo role of ferritin ferroxidase activity. J Biol Chem 275: 25122-25129, 2000.
61. Cozzi A, Corsi B, Levi S, Santambrogio P, Biasiotto G and Arosio P. Analysis of the biologic functions of H- and L-ferritins in HeLa cells by transfection with siRNAs and cDNAs: evidence for a proliferative role of L-ferritin. Blood 103: 2377-2383, 2004.
62. Cozzi A, Santambrogio P, Corsi B, Campanella A, Arosio P, and Levi S. Characterization of the l-ferritin variant 460InsA responsible of a hereditary ferritinopathy disorder. Neurobiol Dis 23: 644-652, 2006.
63. Curtis AR, Fey C, Morris CM, Bindoff LA, Ince PG, Chinnery PF, Coulthard A, Jackson MJ, Jackson AP, McHale DP, Hay D, Barker WA, Markham AF, Bates D, Curtis A, and Burn J. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet 28: 350-354, 2001.
64. Dancis A, Yuan DS, Haile D, Askwith C, Eide D, Moehle C, Kaplan J, and Klausner RD. Molecular characterization of a copper transport protein in S. cerevisiae: an unexpected role for copper in iron transport. Cell 76: 393-402, 1994.
65. De Domenico I, Vaughn MB, Li L, Bagley D, Musci G, Ward DM, and Kaplan J. Ferroportin-mediated mobilization of ferritin iron precedes ferritin degradation by the proteasome. EMBO J 25: 5396-5404, 2006.
66. De Domenico I, Ward DM, di Patti MC, Jeong SY, David S, Musci G, and Kaplan J. Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin. EMBO J 26: 2823-2831, 2007.
67. De Domenico I, Ward DM, Langelier C, Vaughn MB, Nemeth E, Sundquist WI, Ganz T, Musci G, and Kaplan J. The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Mol Biol Cell 18: 2569-2578, 2007.
68. De Domenico I, Ward DM, Musci G, and Kaplan J. Iron overload due to mutations in ferroportin. Haematologica 91: 92-95, 2006.
69. De Domenico I, Ward DM, Nemeth E, Vaughn MB, Musci G, Ganz T, and Kaplan J. The molecular basis of ferroportin-linked hemochromatosis. Proc Natl Acad Sci U S A 102: 8955-8960, 2005.
70. Delatycki MB, Camakaris J, Brooks H, Evans-Whipp T, Thorburn DR, Williamson R, and Forrest SM. Direct evidence that mitochondrial iron accumulation occurs in Friedreich ataxia. Ann Neurol 45: 673-675, 1999.
71. Desmyter L, Dewaele S, Reekmans R, Nystrom T, Contreras R, and Chen C. Expression of the human ferritin light chain in a frataxin mutant yeast affects ageing and cell death. Exp Gerontol 39: 707-715, 2004.
72. Dhe-Paganon S, Shigeta R, Chi YI, Ristow M, and Shoelson SE. Crystal structure of human frataxin. J Biol Chem 275: 30753-30756, 2000.
73. Donovan A, Brownlie A, Zhou Y, Shepard J, Pratt SJ, Moynihan J, Paw BH, Drejer A, Barut B, Zapata A, Law TC, Brugnara C, Lux SE, Pinkus GS, Pinkus JL, Kingsley PD, Palis J, Fleming MD, Andrews NC, and Zon LI. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403: 776-781, 2000.
74. Donovan A, Lima CA, Pinkus JL, Pinkus GS, Zon LI, Robine S, and Andrews NC. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab 1: 191-200, 2005.
75. Drysdale J, Arosio P, Invernizzi R, Cazzola M, Volz A, Corsi B, Biasiotto G, and Levi S. Mitochondrial ferritin: a new player in iron metabolism. Blood Cells Mol Dis 29: 376-383, 2002.
76. Dubljevic V, Sali A, and Goding JW. A conserved RGD (Arg-Gly-Asp) motif in the transferrin receptor is required for binding to transferrin. Biochem J 341: 11-14, 1999.
77. Durr A, Cossee M, Agid Y, Campuzano V, Mignard C, Penet C, Mandel JL, Brice A, and Koenig M. Clinical and genetic abnormalities in patients with Friedreich's ataxia. N Engl J Med 335: 1169-1175, 1996.
78. Elmberg M, Hultcrantz R, Ekbom A, Brandt L, Olsson S, Olsson R, Lindgren S, Loof L, Stal P, Wallerstedt S, Almer S, Sandberg-Gertzen H, and Askling J. Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives. Gastroenterology 125: 1733-1741, 2003.
79. Epsztejn S, Glickstein H, Picard V, Slotki IN, Breuer W, Beaumont C, and Cabantchik ZI. H-ferritin subunit overexpression in erythroid cells reduces the oxidative stress response and induces multidrug resistance properties. Blood 94: 3593-3603, 1999.
80. Fahn S. Description of Parkinson's disease as a clinical syndrome. Ann N Y Acad Sci 991: 1-14, 2003.
81. Faniello MC, Bevilacqua MA, Condorelli G, de Crombrugghe B, Maity SN, Avvedimento VE, Cimino F, and Costanzo F. The B subunit of the CAAT-binding factor NFY binds the central segment of the Co-activator p300. J Biol Chem 274: 7623-7626, 1999.
82. Favreau LV and Pickett CB. Transcriptional regulation of the rat NAD(P)H:quinone reductase gene: identification of regulatory elements controlling basal level expression and inducible expression by planar aromatic compounds and phenolic antioxidants. J Biol Chem 266: 4556-4561, 1991.
83. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Prass CE, Quintana L, Starnes SM, Schatzman RC, Brunke KJ, Drayna DT, Risch NJ, Bacon BR, and Wolff RK. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13: 399-408, 1996.
84. Feder JN, Penny DM, Irrinki A, Lee VK, Lebron JA, Watson N, Tsuchihashi Z, Sigal E, Bjorkman PJ, and Schatzman RC. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci U S A 95: 1472-1477, 1998.
85. Feder JN, Tsuchihashi Z, Irrinki A, Lee VK, Mapa FA, Morikang E, Prass CE, Starnes SM, Wolff RK, Parkkila S, Sly WS, and Schatzman RC. The hemochromatosis founder mutation in HLAH disrupts beta2-microglobulin interaction and cell surface expression. J Biol Chem 272: 14025-14028, 1997.
86. Ferreira C, Bucchini D, Martin ME, Levi S, Arosio P, Grandchamp B, and Beaumont C. Early embryonic lethality of H ferritin gene deletion in mice. J Biol Chem 275: 3021-3024, 2000.
87. Ferreira C, Santambrogio P, Martin ME, Andrieu V, Feldmann G, Hénin D, and Beaumont C. Blood 98: 525-532, 2001.
88. Fleming J, Spinoulas A, Zheng M, Cunningham SC, Ginn SL, McQuilty RC, Rowe PB, and Alexander IE. Partial correction of sensitivity to oxidant stress in Friedreich ataxia patient fibroblasts by frataxin-encoding adeno-associated virus and lentivirus vectors. Hum Gene Ther 16: 947-956, 2005.
89. Fleming MD, Romano MA, Su MA, Garrick LM, Garrick MD, and Andrews NC. Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. Proc Natl Acad Sci U S A 95: 1148-1153, 1998.
90. Fleming MD, Trenor CC, 3rd, Su MA, Foernzler D, Beier DR, Dietrich WF, and Andrews NC. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet 16: 383-386, 1997.
91. Fleming RE, Ahmann JR, Migas MC, Waheed A, Koeffler HP, Kawabata H, Britton RS, Bacon BR, and Sly WS. Targeted mutagenesis of the murine transferrin receptor-2 gene produces hemochromatosis. Proc Natl Acad Sci U S A 99: 10653-10658, 2002.
92. Fleming RE, Migas MC, Holden CC, Waheed A, Britton RS, Tomatsu S, Bacon BR, and Sly WS. Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis. Proc Natl Acad Sci U S A 97: 2214-2219, 2000.
93. Fleming RE, Migas MC, Zhou X, Jiang J, Britton RS, Brunt EM, Tomatsu S, Waheed A, Bacon BR, and Sly WS. Mechanism of increased iron absorption in murine model of hereditary hemochromatosis: increased duodenal expression of the iron transporter DMT1. Proc Natl Acad Sci U S A 96: 3143-3148, 1999.
94. Fleming RE and Sly WS. Ferroportin mutation in autosomal dominant hemochromatosis: loss of function, gain in understanding. J Clin Invest 108: 521-522, 2001.
95. Foury F and Cazzalini O. Deletion of the yeast homologue of the human gene associated with Friedreich's ataxia elicits iron accumulation in mitochondria. FEBS Lett 411: 373-377, 1997.
96. Foury F and Roganti T. Deletion of the mitochondrial carrier genes MRS3 and MRS4 suppresses mitochondrial iron accumulation in a yeast frataxin-deficient strain. J Biol Chem 277: 24475-24483, 2002.
97. Friling RS, Bensimon A, Tichauer Y, and Daniel V. Xenobiotic-inducible expression of murine glutathione S-transferase Ya sub-unit gene is controlled by an electrophile-responsive element. Proc Natl Acad Sci U S A 87: 6258-6262, 1990.
98. Gakh O, Adamec J, Gacy AM, Twesten RD, Owen WG, and Isaya G. Physical evidence that yeast frataxin is an iron storage protein. Biochemistry 41: 6798-6804, 2002.
99. Gakh O, Park S, Liu G, Macomber L, Imlay JA, Ferreira GC, and Isaya G. Mitochondrial iron detoxification is a primary function of frataxin that limits oxidative damage and preserves cell longevity. Hum Mol Genet 15: 467-479, 2006.
100. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102: 783-788, 2003.
101. Ganz T and Nemeth E. Iron imports. IV. Hepcidin and regulation of body iron metabolism. Am J Physiol Gastrointest Liver Physiol 290: G199-G203, 2006.
102. Gelvan D, Fibach E, Meyron-Holtz EG, and Konijn AM. Ferritin uptake by human erythroid precursors is a regulated iron uptake pathway. Blood 88: 3200-3207, 1996.
103. Gerald D, Berra E, Frapart YM, Chan DA, Giaccia AJ, Mansuy D, Pouyssegur J, Yaniv M, and Mechta-Grigoriou F. JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell 118: 781-794, 2004.
104. Gerber J, Muhlenhoff U, and Lill R. An interaction between frataxin and Isu1/Nfs1 that is crucial for Fe/S cluster synthesis on Isu1. EMBO Rep 4: 906-911, 2003.
105. Gerstein M, Anderson BF, Norris GE, Baker EN, Lesk AM, and Chothia C. Domain closure in lactoferrin: two hinges produce a see-saw motion between alternative close-packed interfaces. J Mol Biol 234: 357-372, 1993.
106. Giannetti AM and Bjorkman PJ. HFE and transferrin directly compete for transferrin receptor in solution and at the cell surface. J Biol Chem 279: 25866-25875, 2004.
107. Giannetti AM, Snow PM, Zak O, and Bjorkman PJ. Mechanism for multiple ligand recognition by the human transferrin receptor. PLoS Biol 1: E51, 2003.
108. Gitlin JD. Aceruloplasminemia. Pediatr Res 44: 271-276, 1998.
109. Gonzalez-Cabo P, Vazquez-Manrique RP, Garcia-Gimeno MA, Sanz P, and Palau F. Hum Mol Genet 14: 2091-2098, 2005.
110. Goossen B, Caughman SW, Harford JB, Klausner RD, and Hentze MW. Translational repression by a complex between the iron-responsive element of ferritin mRNA and its specific cytoplasmic binding protein is position-dependent in vivo. EMBO J 9: 4127-4133, 1990.
111. Gordon DM, Shi Q, Dancis A, and Pain D. Maturation of frataxin within mammalian and yeast mitochondria: one-step processing by matrix processing peptidase. Hum Mol Genet 8: 2255-2262, 1999.
112. Grant L, Sun J, Xu H, Subramony SH, Chaires JB, and Hebert MD. Rational selection of small molecules that increase transcription through the GAA repeats found in Friedreich's ataxia. FEBS Lett 580: 5399-5405, 2006.
113. Gray CP, Arosio P, and Hersey P. Association of increased levels of heavy-chain ferritin with increased CD4+ CD25+ regulatory T-cell levels in patients with melanoma. Clin Cancer Res 9: 2551-2559, 2003.
114. Gray CP, Arosio P, and Hersey P. Heavy chain ferritin activates regulatory T cells by induction of changes in dendritic cells. Blood 99: 3326-3334, 2002.
115. Gray NK and Hentze MW. Iron regulatory protein prevents binding of the 43S translation pre-initiation complex to ferritin and eALAS mRNAs. EMBO J 13: 3882-3891, 1994.
116. Greene E, Entezam A, Kumari D, and Usdin K. Ancient repeated DNA elements and the regulation of the human frataxin promoter. Genomics 85: 221-230, 2005.
117. Grossmann JG, Neu M, Evans RW, Lindley PF, Appel H, and Hasnain SS. Metal-induced conformational changes in transferrins. J Mol Biol 229: 585-590, 1993.
118. Grossmann JG, Neu M, Pantos E, Schwab FJ, Evans RW, Townes-Andrews E, Lindley PF, Appel H, Thies WG, and Hasnain SS. X-ray solution scattering reveals conformational changes upon iron uptake in lactoferrin, serum and ovo-transferrins. J Mol Biol 225: 811-819, 1992.
119. Gunshin H, Allerson CR, Polycarpou-Schwarz M, Rofts A, Rogers JT, Kishi F, Hentze MW, Rouault TA, Andrews NC, and Hediger MA. Iron-dependent regulation of the divalent metal ion transporter. FEBS Lett 509: 309-316, 2001.
120. Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF, Nussberger S, Gollan JL, and Hediger MA. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388: 482-488, 1997.
121. Gutteridge JM and Quinlan GJ. Antioxidant protection against organic and inorganic oxygen radicals by normal human plasma: the important primary role for iron-binding and iron-oxidising proteins. Biochim Biophys Acta 1159: 248-254, 1992.
122. Hahn P, Qian Y, Dentchev T, Chen L, Beard J, Harris ZL, and Dunaief JL. Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration. Proc Natl Acad Sci U S A 101: 13850-13855, 2004.
123. Halliwell B. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 18: 685-716, 2001.
124. Han O and Kim EY. Colocalization of ferroportin-1 with hephaestin on the basolateral membrane of human intestinal absorptive cells. J Cell Biochem 101: 1000-1010, 2007.
125. Harris ZL, Davis-Kaplan SR, Gitlin JD, and Kaplan J. A fungal multicopper oxidase restores iron homeostasis in aceruloplasminemia. Blood 103: 4672-4673, 2004.
126. Harris ZL, Durley AP, Man TK, and Gitlin JD. Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc Natl Acad Sci U S A 96: 10812-10817, 1999.
127. Harris ZL, Takahashi Y, Miyajima H, Serizawa M, MacGillivray RT, and Gitlin JD. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci U S A 92: 2539-2543, 1995.
128. Harrison PM and Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1275: 161-203, 1996.
129. Hashimoto M, Hsu LJ, Xia Y, Takeda A, Sisk A, Sundsmo M and Masliah E. Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro. Neuroreport 10: 717-721, 1999.
130. Hentze MW and Argos P. Homology between IRE-BP, a regulatory RNA-binding protein, aconitase, and isopropylmalate isomerase. Nucleic Acids Res 19: 1739-1740, 1991.
131. Hentze MW, Caughman SW, Casey JL, Koeller DM, Rouault TA, Harford JB, and Klausner RD. A model for the structure and functions of iron-responsive elements. Gene 72: 201-208, 1988.
132. Hentze MW, Caughman SW, Rouault TA, Barriocanal JG, Dancis A, Harford JB, and Klausner RD. Identification of the ironresponsive element for the translational regulation of human ferritin mRNA. Science 238: 1570-1573, 1987.
133. Hentze MW and Kuhn LC. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc Natl Acad Sci U S A 93: 8175-8182, 1996.
134. Hentze MW, Muckenthaler MU, and Andrews NC. Balancing acts: molecular control of mammalian iron metabolism. Cell 117: 285-297, 2004.
135. Herman D, Jenssen K, Burnett R, Soragni E, Perlman SL, and Gottesfeld JM. Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia. Nat Chem Biol 2: 551-558, 2006.
136. Hintze KJ and Theil EC. DNA and mRNA elements with complementary responses to hemin, antioxidant inducers, and iron control ferritin-L expression. Proc Natl Acad Sci U S A 102: 15048-15052, 2005.
137. Hochstrasser H, Bauer P, Walter U, Behnke S, Spiegel J, Csoti I, Zeiler B, Bornemann A, Pahnke J, Becker G, Riess O, and Berg D. Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease. Neurology 63: 1912-1917, 2004.
138. Hochstrasser H, Tomiuk J, Walter U, Behnke S, Spiegel J, Kruger R, Becker G, Riess O, and Berg D. Functional relevance of ceruloplasmin mutations in Parkinson's disease. FASEB J 19: 1851-1853, 2005.
139. Holtz WA and O'Malley KL. Parkinsonian mimetics induce aspects of unfolded protein response in death of dopaminergic neurons. J Biol Chem 278: 19367-19377, 2003.
140. Hubert N and Hentze MW. Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: implications for regulation and cellular function. Proc Natl Acad Sci U S A 99: 12345-12350, 2002.
141. Hulet SW, Powers S, and Connor JR. Distribution of transferrin and ferritin binding in normal and multiple sclerotic human brains. J Neurol Sci 165: 48-55, 1999.
142. Hunter HN, Fulton DB, Ganz T, and Vogel HJ. The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis. J Biol Chem 277: 37597-37603, 2002.
143. Iwai K, Drake SK, Wehr NB, Weissman AM, LaVaute T, Minato N, Klausner RD, Levine RL, and Rouault TA. Iron-dependent oxidation, ubiquitination, and degradation of iron regulatory protein 2: implications for degradation of oxidized proteins. Proc Natl Acad Sci U S A 95: 4924-4928, 1998.
144. Iwai K, Klausner RD, and Rouault TA. Requirements for ironregulated degradation of the RNA binding protein, iron regulatory protein 2. EMBO J 14: 5350-5357, 1995.
145. Iwasaki K, Hailemariam K, and Tsuji Y. PIAS3 interacts with ATF1 and regulates the human ferritin H gene through an antioxidant-responsive element. J Biol Chem 282: 22335-22343, 2007.
146. Iwasaki K, Mackenzie EL, Hailemariam K, Sakamoto K, and Tsuji Y. Hemin-mediated regulation of an antioxidant-responsive element of the human ferritin H gene and role of Ref-1 during erythroid differentiation of K562 cells. Mol Cell Biol 26: 2845-2856, 2006.
147. Jacobs EM, Hendriks JC, van Tits BL, Evans PJ, Breuer W, Liu DY, Jansen EH, Jauhiainen K, Sturm B, Porter JB, Scheiber-Mojdehkar B, von Bonsdorff L, Cabantchik ZI, Hider RC, and Swinkels DW. Results of an international round robin for the quantification of serum non-transferrin-bound iron: need for defining standardization and a clinically relevant isoform. Anal Biochem 341: 241-250, 2005.
148. Jauslin ML, Meier T, Smith RA, and Murphy MP. Mitochondria-targeted antioxidants protect Friedreich ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants. FASEB J 17: 1972-1974, 2003.
149. Jauslin ML, Wirth T, Meier T, and Schoumacher F. A cellular model for Friedreich ataxia reveals small-molecule glutathione peroxidase mimetics as novel treatment strategy. Hum Mol Genet 11: 3055-3063, 2002.
150. Jazwinska EC, Cullen LM, Busfield F, Pyper WR, Webb SI, Powell LW, Morris CP, and Walsh TP. Haemochromatosis and HLA-H. Nat Genet 14: 249-251, 1996.
151. Jeong SY and David S. Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. J Biol Chem 278: 27144-27148, 2003.
152. Johnson MB and Enns CA. Diferric transferrin regulates transferrin receptor 2 protein stability. Blood 104: 4287-4293, 2004.
153. Jouanolle AM, Gandon G, Jezequel P, Blayau M, Campion ML, Yaouanq J, Mosser J, Fergelot P, Chauvel B, Bouric P, Carn G, Andrieux N, Gicquel I, Le Gall JY, and David V. Haemochromatosis and HLA-H. Nat Genet 14: 251-252, 1996.
154. Karlberg T, Schagerlof U, Gakh O, Park S, Ryde U, Lindahl M, Leath K, Garman E, Isaya G, and Al-Karadaghi S. The structures of frataxin oligomers reveal the mechanism for the delivery and detoxification of iron. Structure 14: 1535-1546, 2006.
155. Karthikeyan G, Lewis LK, and Resnick MA. The mitochondrial protein frataxin prevents nuclear damage. Hum Mol Genet 11: 1351-1362, 2002.
156. Karthikeyan G, Santos JH, Graziewicz MA, Copeland WC, Isaya G, Van Houten B, and Resnick MA. Reduction in frataxin causes progressive accumulation of mitochondrial damage. Hum Mol Genet 12: 3331-3342, 2003.
157. Kato J, Fujikawa K, Kanda M, Fukuda N, Sasaki K, Takayama T, Kobune M, Takada K, Takimoto R, Hamada H, Ikeda T, and Niitsu Y. A mutation, in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload. Am J Hum Genet 69: 191-197, 2001.
158. Kaufman RJ. Orchestrating the unfolded protein response in health and disease. J Clin Invest 110: 1389-1398, 2002.
159. Kaur D and Andersen J. Does cellular iron dysregulation play a causative role in Parkinson's disease? Ageing Res Rev 3: 327-343, 2004.
160. Kaur D and Andersen JK. Ironing out Parkinson's disease: Is therapeutic treatment with iron chelators a real possibility? Aging Cell 1: 17-21, 2002.
161. Kaur D, Rajagopalan S, Chinta S, Kumar J, Di Monte D, Cherny RA, and Andersen JK. Chronic ferritin expression within murine dopaminergic midbrain neurons results in a progressive age-related neurodegeneration. Brain Res 1140: 188-194, 2007.
162. Kaur D, Yantiri F, Rajagopalan S, Kumar J, Mo JQ, Boonplueang R, Viswanath V, Jacobs R, Yang L, Beal MF, DiMonte D, Volitaskis I, Ellerby L, Cherny RA, Bush AI, and Andersen JK. Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease. Neuron 37: 899-909, 2003.
163. Kawabata H, Yang R, Hirama T, Vuong PT, Kawano S, Gombart AF, and Koeffler HP. Molecular cloning of transferrin receptor 2: a new member of the transferrin receptor-like family. J Biol Chem 274: 20826-20832, 1999.
164. Kim HY, Klausner RD, and Rouault TA. Translational repressor activity is equivalent and is quantitatively predicted by in vitro RNA binding for two iron-responsive element-binding proteins, IRP1 and IRP2. J Biol Chem 270: 4983-4986, 1995.
165. Knight SA, Sepuri NB, Pain D, and Dancis A. Mt-Hsp70 homolog, Ssc2p, required for maturation of yeast frataxin and mitochondrial iron homeostasis. J Biol Chem 273: 18389-18393, 1998.
166. Knutson MD, Oukka M, Koss LM, Aydemir F, and Wessling-Resnick M. Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin. Proc Natl Acad Sci U S A 102: 1324-1328, 2005.
167. Knutson MD, Vafa MR, Haile DJ, and Wessling-Resnick M. Iron loading and erythrophagocytosis increase ferroportin 1 (FPN1) expression in J774 macrophages. Blood 102: 4191-4197, 2003.
168. Konijn AM, Glickstein H, Vaisman B, Meyron-Holtz EG, Slotki IN, and Cabantchik ZI. The cellular labile iron pool and intracellular ferritin in K562 cells. Blood 94: 2128-2134, 1999.
169. Koutnikova H, Campuzano V, Foury F, Dolle P, Cazzalini O, and Koenig M. Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin. Nat Genet 16: 345-351, 1997.
170. Koutnikova H, Campuzano V, and Koenig M. Maturation of wild-type and mutated frataxin by the mitochondrial processing peptidase. Hum Mol Genet 7: 1485-1489, 1998.
171. Krause A, Neitz S, Magert HJ, Schulz A, Forssmann WG, Schulz-Knappe P, and Adermann K. LEAP-1, a novel highly disulfidebonded human peptide, exhibits antimicrobial activity. FEBS Lett 480: 147-150, 2000.
172. Kreuzer M and Kirchgessner M. Endogenous iron excretion: a quantitative means to control iron metabolism? Biol Trace Elem Res 29: 77-92, 1991.
173. Kuchroo VK, Umetsu DT, DeKruyff RH, and Freeman GJ. The TIM gene family: emerging roles in immunity and disease. Nat Rev Immunol 3: 454-462, 2003.
174. Kwak EL, Larochelle DA, Beaumont C, Torti SV, and Torti FM. Role for NF-kappa B in the regulation of ferritin H by tumor necrosis factor-alpha. J Biol Chem 270: 15285-15293, 1995.
175. Langlois d'Estaintot B, Santambrogio P, Granier T, Gallois B, Chevalier JM, Precigoux G, Levi S, and Arosio P. Crystal structure and biochemical properties of the human mitochondrial ferritin and its mutant Ser144Ala. J Mol Biol 340: 277-293, 2004.
176. Larson JA, Howie HL, and So M. Neisseria meningitidis accelerates ferritin degradation in host epithelial cells to yield an essential iron source. Mol Microbiol 53: 807-820, 2004.
177. Latunde-Dada GO, Simpson RJ, and McKie AT. Recent advances in mammalian haem transport. Trends Biochem Sci 31: 182-188, 2006.
178. LaVaute T, Smith S, Cooperman S, Iwai K, Land W, Meyron-Holtz E, Drake SK, Miller G, Abu-Asab M, Tsokos M, Switzer R 3rd, Grinberg A, Love P, Tresser N, and Rouault TA. Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat Genet 27: 209-214, 2001.
179. Lawrence CM, Ray S, Babyonyshev M, Galluser R, Borhani DW, and Harrison SC. Crystal structure of the ectodomain of human transferrin receptor. Science 286: 779-782, 1999.
180. Lawson DM, Artymiuk PJ, Yewdall SJ, Smith JM, Livingstone JC, Treffry A, Luzzago A, Levi S, Arosio P, Cesareni G, Thomas CD, Shaw WV, and Harrison PM. Solving the structure of human H ferritin by genetically engineering intermolecular crystal contacts. Nature 349: 541-544, 1991.
181. Lawson DM, Treffry A, Artymiuk PJ, Harrison PM, Yewdall SJ, Luzzago A, Cesareni G, Levi S, and Arosio P. Identification of the ferroxidase centre in ferritin. FEBS Lett 254: 207-210, 1989.
182. Lebron JA, West AP Jr, and Bjorkman PJ. The hemochromatosis protein HFE competes with transferrin for binding to the transferrin receptor. J Mol Biol 294: 239-245. 1999.
183. Lee DW, Andersen JK, and Kaur D. Iron dysregulation and neurodegeneration: the molecular connection. Mol Interv 6: 89-97, 2006.
184. Lesuisse E, Santos R, Matzanke BF, Knight SA, Camadro JM, and Dancis A. Iron use for haeme synthesis is under control of the yeast frataxin homologue (Yfh1). Hum Mol Genet 12: 879-889, 2003.
185. Levi S, Corsi B, Bosisio M, Invernizzi R, Volz A, Sanford D, Arosio P, and Drysdale J. A human mitochondrial ferritin encoded by an intronless gene. J Biol Chem 276: 24437-24440, 2001.
186. Levi S, Girelli D, Perrone F, Pasti M, Beaumont C, Corrocher R, Albertini A, and Arosio P. Analysis of ferritins in lymphoblastoid cell lines and in the lens of subjects with hereditary hyperferritinemia-cataract syndrome. Blood 91: 4180-4187, 1998.
187. Levy JE, Jin O, Fujiwara Y, Kuo F, and Andrews NC. Transferrin receptor is necessary for development of erythrocytes and the nervous system. Nat Genet 21: 396-399, 1999.
188. Li Y and Jaiswal AK. Regulation of human NAD(P)H:quinone oxidoreductase gene. Role of AP1 binding site contained within human antioxidant response element. J Biol Chem 267: 15097-15104, 1992.
189. Liao QK, Kong PA, Gao J, Li FY, and Qian ZM. Expression of ferritin receptor in placental microvilli membrane in pregnant women with different iron status at mid-term gestation. Eur J Clin Nutr 55: 651-656, 2001.
190. Lill R and Muhlenhoff U. Iron-sulfur protein biogenesis in eukaryotes: components and mechanisms. Annu Rev Cell Dev Biol 22: 457-486, 2006.
191. Liuzzi JP, Aydemir F, Nam H, Knutson MD, and Cousins RJ. Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells. Proc Natl Acad Sci U S A 103: 13612-13617, 2006.
192. Lodi R, Cooper JM, Bradley JL, Manners D, Styles P, Taylor DJ, and Schapira AH. Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia. Proc Natl Acad Sci U S A 96: 11492-11495, 1999.
193. Lok CN and Ponka P. Identification of a hypoxia response element in the transferrin receptor gene. J Biol Chem 274: 24147-24152, 1999.
194. Lu C and Cortopassi G. Frataxin knockdown causes loss of cytoplasmic iron-sulfur cluster functions, redox alterations and induction of heme transcripts. Arch Biochem Biophys 457: 111-122, 2007.
195. Mack U, Powell LW, and Halliday JW. Detection and isolation of a hepatic membrane receptor for ferritin. J Biol Chem 258: 4672-4675, 1983.
196. Mariappan SV, Catasti P, Silks LA 3rd, Bradbury EM, and Gupta G. The high-resolution structure of the triplex formed by the GAA/TTC triplet repeat associated with Friedreich's ataxia. J Mol Biol 285: 2035-2052, 1999.
197. Marziali G, Perrotti E, Ilari R, Testa U, Coccia EM, and Battistini A. Transcriptional regulation of the ferritin heavy-chain gene: the activity of the CCAAT binding factor NF-Y is modulated in heme-treated Friend leukemia cells and during monocyte-to-macrophage differentiation. Mol Cell Biol 17: 1387-1395, 1997.
198. Mayr B and Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2: 599-609, 2001.
199. McIntire JJ, Umetsu SE, Akbari O, Potter M, Kuchroo VK, Barsh GS, Freeman GJ, Umetsu DT, and DeKruyff RH. Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family. Nat Immunol 2: 1109-1116, 2001.
200. McKie AT, Barrow D, Latunde-Dada GO, Rolfs A, Sager G, Mudaly E, Mudaly M, Richardson C, Barlow D, Bomford A, Peters TJ, Raja KB, Shirali S, Hediger MA, Farzaneh F, and Simpson RJ. An iron-regulated ferric reductase associated with the absorption of dietary iron. Science 291: 1755-1759, 2001.
201. McKie AT, Marciani P, Rolfs A, Brennan K, Wehr K, Barrow D, Miret S, Bomford A, Peters TJ, Farzaneh F, Hediger MA, Hentze MW, and Simpson RJ. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 5: 299-309, 2000.
202. Mehlhase J, Sandig G, Pantopoulos K, and Grune T. Oxidation-induced ferritin turnover in microglial cells: role of proteasome. Free Radic Biol Med 38: 276-285, 2005.
203. Meyron-Holtz EG, Ghosh MC, Iwai K, LaVaute T, Brazzolotto X, Berger UV, Land W, Ollivierre-Wilson H, Grinberg A, Love P, and Rouault TA. Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis. EMBO J 23: 386-395, 2004.
204. Millholland JM, Fitch JM, Cai CX, Gibney EP, Beazley KE, and Linsenmayer TF. Ferritoid, a tissue-specific nuclear transport protein for ferritin in corneal epithelial cells. J Biol Chem 278: 23963-23970, 2003.
205. Miranda CJ, Santos MM, Ohshima K, Smith J, Li L, Bunting M, Cossee M, Koenig M, Sequeiros J, Kaplan J, and Pandolfo M. Frataxin knockin mouse. FEBS Lett 512: 291-297, 2002.
206. Miranda CJ, Santos MM, Ohshima K, Tessaro M, Sequeiros J, and Pandolfo M. Frataxin overexpressing mice. FEBS Lett 572: 281-288, 2004.
207. Missirlis F, Holmberg S, Georgieva T, Dunkov BC, Rouault TA, and Law JH. Characterization of mitochondrial ferritin in Drosophila. Proc Natl Acad Sci U S A 103: 5893-5898, 2006.
208. Montosi G, Donovan A, Totaro A, Garuti C, Pignatti E, Cassanelli S, Trenor CC, Gasparini P, Andrews NC, and Pietrangelo A. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 108: 619-623, 2001.
209. Moos T and Morgan EH. The metabolism of neuronal iron and its pathogenic role in neurological disease: review. Ann N Y Acad Sci 1012: 14-26, 2004.
210. Mori K. Tripartite management of unfolded proteins in the endoplasmic reticulum. Cell 101: 451-454, 2000.
211. Moss D, Fargion S, Fracanzani AL, Levi S, Cappellini MD, Arosio P, Powell LW, and Halliday JW. Functional roles of the ferritin receptors of human liver, hepatoma, lymphoid and erythroid cells. J Inorg Biochem 47: 219-227, 1992.
212. Muhlenhoff U, Richhardt N, Ristow M, Kispal G, and Lill R. The yeast frataxin homolog Yfh1p plays a specific role in the maturation of cellular Fe/S proteins. Hum Mol Genet 11: 2025-2036, 2002.
213. Muir WA, McLaren GD, Braun W, and Askari A. Evidence for heterogeneity in hereditary hemochromatosis: evaluation of 174 persons in nine families. Am J Med 76: 806-814, 1984.
214. Mullner EW and Kuhn LC. A stem-loop in the 3′ untranslated region mediates iron-dependent regulation of transferrin receptor mRNA stability in the cytoplasm. Cell 53: 815-825, 1988.
215. Musco G, Stier G, Kolmerer B, Adinolfi S, Martin S, Frenkiel T, Gibson T, and Pastore A. Towards a structural understanding of Friedreich's ataxia: the solution structure of frataxin. Structure 8: 695-707, 2000.
216. Nemeth E, Preza GC, Jung CL, Kaplan J, Waring AJ, and Ganz T. The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study. Blood 107: 328-333, 2006.
217. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, and Ganz T. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113: 1271-1276, 2004.
218. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, and Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306: 2090-2093, 2004.
219. Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A, and Vaulont S. Proc Natl Acad Sci USA 98: 8780-8785, 2001.
220. Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, Beaumont C, Kahn A, and Vaulont S. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 110: 1037-1044, 2002.
221. Niederkofler V, Salie R, and Arber S. Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload. J Clin Invest 115: 2180-2186, 2005.
222. Njajou OT, Vaessen N, Joosse M, Berghuis B, van Dongen JW, Breuning MH, Snijders PJ, Rutten WP, Sandkuijl LA, Oostra BA, van Duijn CM, and Heutink P. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet 28: 213-214, 2001.
223. Nohe A, Keating E, Knaus P, and Petersen NO. Signal transduction of bone morphogenetic protein receptors. Cell Signal 16: 291-299, 2004.
224. Oakley AE, Collingwood JF, Dobson J, Love G, Perrott HR, Edwardson JA, Elstner M, and Morris CM. Individual dopaminergic neurons show raised iron levels in Parkinson disease. Neurology 68: 1820-1825, 2007.
225. Ohgami RS, Campagna DR, Antiochos B, Wood EB, Sharp JJ, Barker JE, and Fleming MD. nm1054: a spontaneous, recessive, hypochromic, microcytic anemia mutation in the mouse. Blood 106: 3625-3631, 2005.
226. Ohgami RS, Campagna DR, Greer EL, Antiochos B, McDonald A, Chen J, Sharp JJ, Fujiwara Y, Barker JE, and Fleming MD. Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells. Nat Genet 37: 1264-1269, 2005.
227. Ohshima K, Montermini L, Wells RD, and Pandolfo M. Inhibitory effects of expanded GAA.TTC triplet repeats from intron I of the Friedreich ataxia gene on transcription and replication in vivo. J Biol Chem 273: 14588-14595, 1998.
228. Oktay Y, Dioum E, Matsuzaki S, Ding K, Yan LJ, Haller RG, Szweda LI, and Garcia JA. Hypoxia-inducible factor 2alpha regulates expression of the mitochondrial aconitase chaperone protein frataxin. J Biol Chem 282: 11750-11756, 2007.
229. Okuda A, Imagawa M, Maeda Y, Sakai M, and Muramatsu M. Structural and functional analysis of an enhancer GPEI having a phorbol 12-O-tetradecanoate 13-acetate responsive element-like sequence found in the rat glutathione transferase P gene. J Biol Chem 264: 16919-16926, 1989.
230. Ollinger K and Roberg K. Nutrient deprivation of cultured rat hepatocytes increases the desferrioxamine-available iron pool and augments the sensitivity to hydrogen peroxide. J Biol Chem 272: 23707-23711, 1997.
231. Orino K, Lehman L, Tsuji Y, Ayaki H, Torti SV, and Torti FM. Ferritin and the response to oxidative stress. Biochem J 357: 241-247, 2001.
232. Osaki S. Kinetic studies of ferrous ion oxidation with crystalline human ferroxidase (ceruloplasmin). J Biol Chem 241: 5053-5059, 1966.
233. Papanikolaou G and Pantopoulos K. Iron metabolism and toxicity. Toxicol Appl Pharmacol 202: 199-211, 2005.
234. Papanikolaou G, Samuels ME, Ludwig EH, MacDonald ML, Franchini PL, Dube MP, Andres L, MacFarlane J, Sakellaropoulos N, Politou M, Nemeth E, Thompson J, Risler JK, Zaborowska C, Babakaiff R, Radomski CC, Pape TD, Davidas O, Christakis J, Brissot P, Lockitch G, Ganz T, Hayden MR, and Goldberg YP. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 36: 77-82, 2004.
235. Paradkar PN and Roth JA. Post-translational and transcriptional regulation of DMT1 during P19 embryonic carcinoma cell differentiation by retinoic acid. Biochem J 394: 173-183, 2006.
236. Park CH, Valore EV, Waring AJ, and Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276: 7806-7810, 2001.
237. Park S, Gakh O, Mooney SM, and Isaya G. The ferroxidase activity of yeast frataxin. J Biol Chem 277: 38589-38595, 2002.
238. Park S, Gakh O, O'Neill HA, Mangravita A, Nichol H, Ferreira GC, and Isaya G. Yeast frataxin sequentially chaperones and stores iron by coupling protein assembly with iron oxidation. J Biol Chem 278: 31340-31351, 2003.
239. Parkkila S, Waheed A, Britton RS, Bacon BR, Zhou XY, Tomatsu S, Fleming RE, and Sly WS. Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci U S A 94: 13198-13202, 1997.
240. Pastore A, Tozzi G, Gaeta LM, Bertini E, Serafini V, Di Cesare S, Bonetto V, Casoni F, Carrozzo R, Federici G, and Piemonte F. Actin glutathionylation increases in fibroblasts of patients with Friedreich's ataxia: a potential role in the pathogenesis of the disease. J Biol Chem 278: 42588-42595, 2003.
241. Patel BN and David S. A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes. J Biol Chem 272: 20185-20190, 1997.
242. Patel BN, Dunn RJ, and David S. Alternative RNA splicing generates a glycosylphosphatidylinositol-anchored form of ceruloplasmin in mammalian brain. J Biol Chem 275: 4305-4310, 2000.
243. Patel BN, Dunn RJ, Jeong SY, Zhu Q, Julien JP, and David S. Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. J Neurosci 22: 6578-6586, 2002,
244. Perkins ND. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 8: 49-62, 2007.
245. Perry G, Cash AD, and Smith MA. Alzheimer disease and oxidative stress. J Biomed Biotechnol 2: 120-123, 2002.
246. Peyssonnaux C, Zinkernagel AS, Schuepbach RA, Rankin E, Vaulont S, Haase VH, Nizet V, and Johnson RS. Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). J Clin Invest 117: 1926-1932, 2007.
247. Pham CG, Bubici C, Zazzeroni F, Papa S, Jones J, Alvarez K, Jayawardena S, De Smaele E, Cong R, Beaumont C, Torti FM, Torti SV, and Franzoso G. Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell 119: 529-542, 2004.
248. Pietrangelo A. Hereditary hemochromatosis: a new look at an old disease. N Engl J Med 350: 2383-2397, 2004.
249. Pietrangelo A, Dierssen U, Valli L, Garuti C, Rump A, Corradini E, Ernst M, Klein C, and Trautwein C. STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo. Gastroenterology 132: 294-300, 2007.
250. Pietsch EC, Chan JY, Torti FM, and Torti SV. Nrf2 mediates the induction of ferritin H in response to xenobiotics and cancer chemopreventive dithiolethiones. J Biol Chem 278: 2361-2369, 2003.
251. Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, and Loreal O. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276: 7811-7819, 2001.
252. Pilz RB. Impaired erythroid-specific gene expression in cAMP-dependent protein kinase-deficient murine erythroleukemia cells. J Biol Chem 268: 20252-20258, 1993.
253. Ponka P, Beaumont C, and Richardson DR. Function and regulation of transferrin and ferritin. Semin Hematol 35: 35-54, 1998.
254. Prieto J, Barry M, and Sherlock S. Serum ferritin in patients with iron overload and with acute and chronic liver diseases. Gastroenterology 68: 525-533, 1975.
255. Puccio H, Simon D, Cossee M, Criqui-Filipe P, Tiziano F, Melki J, Hindelang C, Matyas R, Rustin P, and Koenig M. Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat Genet 27: 181-186, 2001.
256. Radisky DC, Babcock MC, and Kaplan J. The yeast frataxin homologue mediates mitochondrial iron efflux: evidence for a mitochondrial iron cycle. J Biol Chem 274: 4497-4499, 1999.
257. Rangasamy T, Cho CY, Thimmulappa RK, Zhen L, Srisuma SS, Kensler TW, Yamamoto M, Petrache I, Tuder RM, and Biswal S. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J Clin Invest 114: 1248-1259, 2004.
258. Rangasamy T, Guo J, Mitzner WA, Roman J, Singh A, Fryer AD, Yamamoto M, Kensler TW, Tuder RM, Georas SN, and Biswal S. Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice. J Exp Med 202: 47-59, 2005.
259. Reinheckel T, Sitte N, Ullrich O, Kuckelkorn U, Davies KJ. and Grune T. Comparative resistance of the 20S and 26S proteasome to oxidative stress. Biochem J 335: 637-642, 1998.
260. Rennert PD, Ichimura T, Sizing ID, Bailly V, Li Z, Rennard R, McCoon P, Pablo L, Miklasz S, Tarilonte L, and Bonventre JV. T cell, Ig domain, mucin domain-2 gene-deficient mice reveal a novel mechanism for the regulation of Th2 immune responses and airway inflammation. J Immunol 177: 4311-4321, 2006.
261. Richardson DR, Mouralian C, Ponka P, and Becker E. Development of potential iron chelators for the treatment of Friedreich's ataxia: ligands that mobilize mitochondrial iron. Biochim Biophys Acta 1536: 133-140, 2001.
262. Rivera S, Nemeth E, Gabayan V, Lopez MA, Farshidi D, and Ganz T. Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. Blood 106: 2196-2199, 2005.
263. Roetto A, Papanikolaou G, Politou M, Alberti F, Girelli D, Christakis J, Loukopoulos D, and Camaschella C. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 33: 21-22, 2003.
264. Rogers JT, Randall JD, Cahill CM, Eder PS, Huang X, Gunshin H, Leiter L, McPhee J, Sarang SS, Utsuki T, Greig NH, Lahiri DK, Tanzi RE, Bush AI, Giordano T, and Gullans SR. An iron-responsive element type II in the 5′-untranslated region of the Alzheimer's amyloid precursor protein transcript. J Biol Chem 277: 45518-45528, 2002.
265. Rotig A, de Lonlay P, Chretien D, Foury F, Koenig M, Sidi D, Munnich A, and Rustin P. Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat Genet 17: 215-217, 1997.
266. Rouault TA, Hentze MW, Caughman SW, Harford JB, and Klausner RD. Binding of a cytosolic protein to the iron-responsive element of human ferritin messenger RNA. Science 241: 1207-1210, 1988.
267. Rouault TA, Stout CD, Kaptain S, Harford JB, and Klausner RD. Structural relationship between an iron-regulated RNA-binding protein (IRE-BP) and aconitase: functional implications. Cell 64: 881-883, 1991.
268. Rubinsztein DC, Gestwicki JE, Murphy LO, and Klionsky DJ. Potential therapeutic applications of autophagy. Nat Rev Drug Discov 6: 304-312, 2007.
269. Rushmore TH, Morton MR, and Pickett CB. The antioxidant responsive element: activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J Biol Chem 266: 11632-11639, 1991.
270. Ryu EJ, Harding HP, Angelastro JM, Vitolo OV, Ron D, and Greene LA. Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease. J Neurosci 22: 10690-10698, 2002.
271. Sakamoto N, Chastain PD, Parniewski P, Ohshima K, Pandolfo M, Griffith JD, and Wells RD. Sticky DNA: self-association properties of long GAA.TTC repeats in R.R.Y triplex structures from Friedreich's ataxia. Mol Cell 3: 465-475, 1999.
272. Sakamoto N, Ohshima K, Montermini L, Pandolfo M, and Wells RD. Sticky DNA, a self-associated complex formed at long GAA*TTC repeats in intron 1 of the frataxin gene, inhibits transcription. J Biol Chem 276: 27171-27177, 2001.
273. Schalinske KL and Eisenstein RS. Phosphorylation and activation of both iron regulatory proteins 1 and 2 in HL-60 cells. J Biol Chem 271: 7168-7176, 1996.
274. Schoenfeld RA, Napoli E, Wong A, Zhan S, Reutenauer L, Morin D, Buckpitt AR, Taroni F, Lonnerdal B, Ristow M, Puccio H, and Cortopassi GA. Frataxin deficiency alters heme pathway transcripts and decreases mitochondrial heme metabolites in mammalian cells. Hum Mol Genet 14: 3787-3799, 2005.
275. Schranzhofer M, Schifrer M, Cabrera JA, Kopp S, Chiba P, Beug H, and Mullner EW. Remodeling the regulation of iron metabolism during erythroid differentiation to ensure efficient heme biosynthesis. Blood 107: 4159-4167, 2006.
276. Semenza GL. HIF-1 and mechanisms of hypoxia sensing. Curr Opin Cell Biol 13: 167-171, 2001.
277. Seznec H, Simon D, Bouton C, Reutenauer L, Hertzog A, Golik P, Procaccio V, Patel M, Drapier JC, Koenig M, and Puccio H. Friedreich ataxia: the oxidative stress paradox. Hum Mol Genet 14: 463-474, 2005.
278. Seznec H, Simon D, Monassier L, Criqui-Filipe P, Gansmuller A, Rustin P, Koenig M, and Puccio H. Idebenone delays the onset of cardiac functional alteration without correction of Fe-S enzymes deficit in a mouse model for Friedreich ataxia. Hum Mol Genet 13: 1017-1024, 2004.
279. Shalitin S, Carmi D, Weintrob N, Phillip M, Miskin H, Kornreich L, Zilber R, Yaniv I, and Tamary H. Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients. Eur J Haematol 74: 93-100, 2005.
280. Shan Y, Napoli E, and Cortopassi G. Hum Mol Genet 16: 929-941, 2007.
281. Shang T, Kotamraju S, Kalivendi SV, Hillard CJ, and Kalyanaraman B. 1-Methyl-4-phenylpyridinium-induced apoptosis in cerebellar granule neurons is mediated by transferrin receptor iron-dependent depletion of tetrahydrobiopterin and neuronal nitric-oxide synthase-derived superoxide. J Biol Chem 279: 19099-19112, 2004.
282. Shayeghi M, Latunde-Dada GO, Oakhill JS, Laftah AH, Takeuchi K, Halliday N, Khan Y, Warley A, McCann FE, Hider RC, Frazer DM, Anderson GJ, Vulpe CD, Simpson RJ, and McKie AT. Identification of an intestinal heme transporter. Cell 122: 789-801, 2005.
283. Silvestri L, Pagani A, Fazi C, Gerardi G, Levi S, Arosio P, and Camaschella C. Defective targeting of hemojuvelin to plasma membrane is a common pathogenetic mechanism in juvenile hemochromatosis. Blood 109: 4503-4510, 2007.
284. Simon D, Seznec H, Gansmuller A, Carelle N, Weber P, Metzger D, Rustin P, Koenig M, and Puccio H. Friedreich ataxia mouse models with progressive cerebellar and sensory ataxia reveal autophagic neurodegeneration in dorsal root ganglia. J Neurosci 24: 1987-1995, 2004.
285. Smith MA, Wehr K, Harris PL, Siedlak SL, Connor JR and Perry G. Abnormal localization of iron regulatory protein in Alzheimer's disease. Brain Res 788: 232-236, 1998.
286. Stehling O, Elsasser HP, Bruckel B, Muhlenhoff U, and Lill R. Iron-sulfur protein maturation in human cells: evidence for a function of frataxin. Hum Mol Genet 13: 3007-3015, 2004.
287. Storch S, Kubler B, Honing S, Ackmann M, Zapf J, Blum W, and Braulke T. Transferrin binds insulin-like growth factors and affects binding properties of insulin-like growth factor binding protein-3. FEBS Lett 509: 395-398, 2001.
288. Sturm B, Bistrich U, Schranzhofer M, Sarsero JP, Rauen U, Scheiber-Mojdehkar B, de Groot H, Ioannou P, and Petrat F. Friedreich's ataxia, no changes in mitochondrial labile iron in human lymphoblasts and fibroblasts: a decrease in antioxidative capacity? J Biol Chem 280: 6701-6708, 2005.
289. Sturm B, Stupphann D, Kaun C, Boesch S, Schranzhofer M, Wojta J, Goldenberg H, and Scheiber-Mojdehkar B. Recombinant human erythropoietin: effects on frataxin expression in vitro. Eur J Clin Invest 35: 711-717, 2005.
290. Surguladze N, Patton S, Cozzi A, Fried MG, and Connor JR. Characterization of nuclear ferritin and mechanism of translocation. Biochem J 388: 731-740, 2005.
291. Tabuchi M, Tanaka N, Nishida-Kitayama J, Ohno H, and Kishi F. Alternative splicing regulates the subcellular localization of divalent metal transporter 1 isoforms. Mol Biol Cell 13: 4371-4387, 2002.
292. Tan G, Chen LS, Lonnerdal B, Gellera C, Taroni FA, and Cortopassi GA. Frataxin expression rescues mitochondrial dysfunctions in FRDA cells. Hum Mol Genet 10: 2099-2107, 2001.
293. Tehranchi R, Invernizzi R, Grandien A, Zhivotovsky B, Fadeel B, Forsblom AM, Travaglino E, Samuelsson J, Hast R, Nilsson L, Cazzola M, Wibom R, and Hellstrom-Lindberg E. Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes. Blood 106: 247-253, 2005.
294. Thierbach R, Schulz TJ, Isken F, Voigt A, Mietzner B, Drewes G, von Kleist-Retzow JC, Wiesner RJ, Magnuson MA, Puccio H, Pfeiffer AF, Steinberg P, and Ristow M. Targeted disruption of hepatic frataxin expression causes impaired mitochondrial function, decreased life span and tumor growth in mice. Hum Mol Genet 14: 3857-3864, 2005.
295. Thimmulappa RK, Mai KH, Srisuma S, Kensler TW, Yamamoto M, and Biswal S. Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res 62: 5196-5203, 2002.
296. Thompson K, Menzies S, Muckenthaler M, Torti FM, Wood T, Torti SV, Hentze MW, Beard J, and Connor J. Mouse brains deficient in H-ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress. J Neurosci Res 71: 46-63, 2003.
297. Thompson KJ, Fried MG, Ye Z, Boyer P, and Connor JR. Regulation, mechanisms and proposed function of ferritin translocation to cell nuclei. J Cell Sci 115: 2165-2177, 2002.
298. Thorstensen K and Romslo I. The role of transferrin in the mechanism of cellular iron uptake. Biochem J 271: 1-9, 1990.
299. Torti SV, Kwak EL, Miller SC, Miller LL, Ringold GM, Myambo KB, Young AP, and Torti FM. The molecular cloning and characterization of murine ferritin heavy chain, a tumor necrosis factor-inducible gene. J Biol Chem 263: 12638-12644, 1988.
300. Toth I, Yuan L, Rogers JT, Boyce H, and Bridges KR. Hypoxia alters iron-regulatory protein-1 binding capacity and modulates cellular iron homeostasis in human hepatoma and erythroleukemia cells. J Biol Chem 274: 4467-4473, 1999.
301. Toussaint L, Bertrand L, Hue L, Crichton RR, and Declercq JP. High-resolution X-ray structures of human apoferritin H-chain mutants correlated with their activity and metal-binding sites. J Mol Biol 365: 440-452, 2007.
302. Tran TN, Eubanks SK, Schaffer KJ, Zhou CY, and Linder MC. Secretion of ferritin by rat hepatoma cells and its regulation by inflammatory cytokines and iron. Blood 90: 4979-4986, 1997.
303. Trinder D and Baker E. Transferrin receptor 2: a new molecule in iron metabolism. Int J Biochem Cell Biol 35: 292-296, 2003.
304. Trinder D, Fox C, Vautier G, and Olynyk JK. Molecular pathogenesis of iron overload. Gut 51: 290-295, 2002.
305. Truksa J, Peng H, Lee P, and Beutler E. Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6. Proc Natl Acad Sci U S A 103: 10289-10293, 2006.
306. Tsuji Y. JunD activates transcription of the human ferritin H gene through an antioxidant response element during oxidative stress. Oncogene 24: 7567-7578, 2005.
307. Tsuji Y, Akebi N, Lam TK, Nakabeppu Y, Torti SV, and Torti FM. FER-1, an enhancer of the ferritin H gene and a target of E1A-mediated transcriptional repression. Mol Cell Biol 15: 5152-5164, 1995.
308. Tsuji Y, Ayaki H, Whitman SP, Morrow CS, Torti SV, and Torti FM. Coordinate transcriptional and translational regulation of ferritin in response to oxidative stress. Mol Cell Biol 20: 5818-5827, 2000.
309. Tsuji Y, Kwak E, Saika T, Torti SV, and Torti FM. Preferential repression of the H subunit of ferritin by adenovirus E1A in NIH-3T3 mouse fibroblasts. J Biol Chem 268: 7270-7275, 1993.
310. Tsuji Y, Miller LL, Miller SC, Torti SV, and Torti FM. Tumor necrosis factor-alpha and interleukin 1-alpha regulate transferrin receptor in human diploid fibroblasts: relationship to the induction of ferritin heavy chain. J Biol Chem 266: 7257-7261, 1991.
311. Tsuji Y, Moran E, Torti SV, and Torti FM. Transcriptional regulation of the mouse ferritin H gene: involvement of p300/CBP adaptor proteins in FER-1 enhancer activity. J Biol Chem 274: 7501-7507, 1999.
312. Tsuji Y, Torti SV, and Torti FM. Activation of the ferritin H enhancer, FER-1, by the cooperative action of members of the AP1 and Sp1 transcription factor families. J Biol Chem 273: 2984-2992, 1998.
313. Turano M, Tammaro A, De Biase I, Lo Casale MS, Ruggiero G, Monticelli A, Cocozza S, and Pianese L. 3-Nitropropionic acid increases frataxin expression in human lymphoblasts and in transgenic rat PC12 cells. Neurosci Lett 350: 184-186, 2003.
314. Vahdat Shariatpanaahi M, Vahdat Shariatpanaahi Z, Moshtaaghi M, Shahbaazi SH, and Abadi A. The relationship between depression and serum ferritin level. Eur J Clin Nutr 61: 532-535, 2007.
315. Verga Falzacappa MV, Vujic Spasic M, Kessler R, Stolte J, Hentze MW, and Muckenthaler MU. STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood 109: 353-358, 2007.
316. Vidal R, Ghetti B, Takao M, Brefel-Courbon C, Uro-Coste E, Glazier BS, Siani V, Benson MD, Calvas P, Miravalle L, Rascol O, and Delisle MB. Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene. J Neuropathol Exp Neurol 63: 363-380, 2004.
317. Voisine C, Schilke B, Ohlson M, Beinert H, Marszalek J, and Craig EA. Role of the mitochondrial Hsp70s, Ssc1 and Ssq1, in the maturation of Yfh1. Mol Cell Biol 20: 3677-3684, 2000.
318. Vulpe CD, Kuo YM, Murphy TL, Cowley L, Askwith C, Libina N, Gitschier J and Anderson GJ. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat Genet 21: 195-199, 1999.
319. Waheed A, Grubb JH, Zhou XY, Tomatsu S, Fleming RE, Costaldi ME, Britton RS, Bacon BR, and Sly WS. Regulation of transferrin-mediated iron uptake by HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci U S A 99: 3117-3122, 2002.
320. Waheed A, Parkkila S, Saarnio J, Fleming RE, Zhou XY, Tomatsu S, Britton RS, Bacon BR and Sly WS. Association of HFE protein with transferrin receptor in crypt enterocytes of human duodenum. Proc Natl Acad Sci U S A 96: 1579-1584, 1999.
321. Waheed A, Parkkila S, Zhou XY, Tomatsu S, Tsuchihashi Z, Feder JN, Schatzman RC, Britton RS, Bacon BR, and Sly WS. Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proc Natl Acad Sci U S A 94: 12384-12389, 1997.
322. Walden WE, Selezneva AI, Dupuy J, Volbeda A, Fontecilla-Camps JC, Theil EC, and Volz K. Structure of dual function iron regulatory protein 1 complexed with ferritin IRE-RNA. Science 314: 1903-1908, 2006.
323. Wallace DF, Summerville L, Lusby PE, and Subramaniam VN. Gut 54: 980-986, 2005.
324. Weinzimer SA, Gibson TB, Collett-Solberg PF, Khare A, Liu B, and Cohen P. Transferrin is an insulin-like growth factor-binding protein-3 binding protein. J Clin Endocrinol Metab 86: 1806-1813, 2001.
325. Wenger RH, Stiehl DP, and Camenisch G. Integration of oxygen signaling at the consensus HRE. Sci STKE 2005: re12, 2005.
326. West AP Jr, Bennett MJ, Sellers VM, Andrews NC, Enns CA, and Bjorkman PJ. Comparison of the interactions of transferrin receptor and transferrin receptor 2 with transferrin and the hereditary hemochromatosis protein HFE. J Biol Chem 275: 38135-38138, 2000.
327. Wong A, Yang J, Cavadini P, Gellera C, Lonnerdal B, Taroni F, and Cortopassi G. The Friedreich's ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis. Hum Mol Genet 8: 425-430, 1999.
328. Worwood M, Brook JD, Cragg SJ, Hellkuhl B, Jones BM, Perera P, Roberts SH, and Shaw DJ. Assignment of human ferritin genes to chromosomes 11 and 19q13.3 - 19qter. Hum Genet 69: 371-374, 1985.
329. Worwood M, Dawkins S, Wagstaff M, and Jacobs A. The purification and properties of ferritin from human serum. Biochem J 157: 97-103, 1976.
330. Wrighting DM and Andrews NC. Interleukin-6 induces hepcidin expression through STAT3. Blood 108: 3204-3209, 2006.
331. Xanthoudakis S and Curran T. Redox regulation of AP-1: a link between transcription factor signaling and DNA repair. Adv Exp Med Biol 387: 69-75, 1996.
332. Xu X, Pin S, Gathinji M, Fuchs R, and Harris ZL. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. Ann N Y Acad Sci 1012: 299-305, 2004.
333. Yamamuro A, Yoshioka Y, Ogita K, and Maeda S. Involvement of endoplasmic reticulum stress on the cell death induced by 6-hydroxydopamine in human neuroblastoma SH-SY5Y cells. Neurochem Res 31: 657-664, 2006.
334. Yamanaka K, Ishikawa H, Megumi Y, Tokunaga F, Kanie M, Rouault TA, Morishima I, Minato N, Ishimori K, and Iwai K. Identification of the ubiquitin-protein ligase that recognizes oxidized IRP2. Nat Cell Biol 5: 336-340, 2003.
335. Yang F, Liu XB, Quinones M, Melby PC, Ghio A, and Haile DJ. Regulation of reticuloendothelial iron transporter MTP1 (Slc11a3) by inflammation. J Biol Chem 277: 39786-39791, 2002.
336. Yang F, Lum JB, McGill JR, Moore CM, Naylor SL, van Bragt PH, Baldwin WD, and Bowman BH. Human transferrin: cDNA characterization and chromosomal localization. Proc Natl Acad Sci U S A 81: 2752-2756, 1984.
337. Yoon T and Cowan JA. Frataxin-mediated iron delivery to ferrochelatase in the final step of heme biosynthesis. J Biol Chem 279: 25943-25946, 2004.
338. Zancani M, Peresson C, Biroccio A, Federici G, Urbani A, Murgia I, Soave C, Micali F, Vianello A, and Macri F. Evidence for the presence of ferritin in plant mitochondria. Eur J Biochem 271: 3657-3664, 2004.
339. Zecca L, Stroppolo A, Gatti A, Tampellini D, Toscani M, Gallorini M, Giaveri G, Arosio P, Santambrogio P, Fariello RG, Karatekin E, Kleinman MH, Turro N, Hornykiewicz O, and Zucca FA. The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. Proc Natl Acad Sci U S A 101: 9843-9848, 2004.
340. Zecca L, Youdim MB, Riederer P, Connor JR, and Crichton RR. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5: 863-873, 2004.
341. Zhang Y, Lyver ER, Knight SA, Lesuisse E, and Dancis A. Frataxin and mitochondrial carrier proteins, Mrs3p and Mrs4p, cooperate in providing iron for heme synthesis. J Biol Chem 280: 19794-19807, 2005.
342. Zhou XY, Tomatsu S, Fleming RE, Parkkila S, Waheed A, Jiang J, Fei Y, Brunt EM, Ruddy DA, Prass CE, Schatzman RC, O'Neill R, Britton RS, Bacon BR, and Sly WS. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci U S A 95: 2492-2497, 1998.